Pictet Asset Management’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RCMNY
PA
BI
NI
Pictet Asset Management's ZYME Position: Q2 2026 in Review
Pictet Asset Management increased its Zymeworks (ZYME) stake by 3,230% in Q2 2026, buying an estimated $7.6M and bringing the position to 308,187 shares worth $7.45M. The position accounts for 0.01% of the portfolio, ranked #735.
Pictet Asset Management first reported a position in ZYME in Q4 2025 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.
- Pictet Asset Management held 308,187 shares of Zymeworks worth $7.45M as of Q2 2026.
- Pictet Asset Management bought 298,931 Zymeworks shares in Q2 2026, an estimated $7.6M.
- Zymeworks made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #735 holding.
- Pictet Asset Management first reported a position in Zymeworks in Q4 2025 and has held it in 3 quarters since.
- 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.